Table 1. Comparison of demographics and pharmaceutical therapy for patients with CAC and without CAC at time of non-gated chest CT.

CAC - coronary artery calcium; OR - odds ratio; CI - confidence interval; DM2 - diabetes mellitus type 2; HTN - hypertension; HLP - hyperlipidemia; CAD - coronary artery disease; CT - computed tomography

	CAC  (n=3119)	No CAC  (n=1834)	OR predicting CAC with 95% CI	p-value
Age (years)	71±11	48±17		<0.0001
Male gender	1793 (57.5%)	891 (48.6%)	1.43 (1.27-1.61)	<0.0001
Smoker	1346 (43.2%)	493 (26.9%)	2.07 (1.82-2.34)	<0.0001
DM2	938 (30.1%)	252 (13.7%)	2.70 (2.32-3.15)	<0.0001
HTN	2578 (82.7%)	839 (45.7%)	5.65 (4.96-6.44)	<0.0001
HLP	2321 (74.4%)	704 (38.4%)	4.67 (4.12-5.28)	<0.0001
Known CAD	1148 (36.8%)	178 (9.7%)	5.42 (4.57-6.42)	<0.0001
Pre-CT statin	1960 (62.8%)	440 (24.0%)	5.18 (4.55-5.90)	<0.0001
Pre-CT nonstatin	451 (14.5%)	106 (5.8%)	2.76 (2.21-3.43)	<0.0001
Pre-CT aspirin	1827 (58.6%)	433 (23.6%)	4.58 (4.02-5.21)	<0.0001